FBL20 Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that can indirectly inhibit FBL20 by preventing the degradation of proteins that regulate its activity. By stabilizing these regulatory proteins, MG132 can lead to the functional inhibition of FBL20. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is another proteasome inhibitor that can lead to the accumulation of FBL20 regulatory proteins, which can inhibit its function by potentially altering its interaction with substrates or other proteins involved in its signaling pathway. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
Epoxomicin selectively inhibits the proteasome, thereby stabilizing proteins that regulate FBL20 activity. This can result in an inhibition of FBL20 function due to the disruption of its normal regulatory degradation processes. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
Lactacystin is a proteasome inhibitor that can indirectly inhibit FBL20 by preventing the proteasomal degradation of proteins that regulate FBL20, thus affecting its activity. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $73.00 $148.00 $316.00 $499.00 $1427.00 $101.00 | 19 | |
Leupeptin inhibits lysosomal proteases, which can lead to the accumulation of regulatory proteins of FBL20 within the cell, thus potentially inhibiting FBL20 function by interfering with its normal protein turnover. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
E-64 is a cysteine protease inhibitor that can indirectly affect FBL20 by stabilizing its regulatory proteins. This can inhibit the functional activity of FBL20 by preventing the normal proteolytic processing that is required for its function. | ||||||
Chymostatin | 9076-44-2 | sc-202541 sc-202541A sc-202541B sc-202541C sc-202541D | 5 mg 10 mg 25 mg 50 mg 100 mg | $156.00 $260.00 $640.00 $1186.00 $2270.00 | 3 | |
Chymostatin inhibits chymotrypsin-like proteases, which can result in the accumulation of proteins that regulate the function of FBL20, leading to its functional inhibition. | ||||||
Aprotinin | 9087-70-1 | sc-3595 sc-3595A sc-3595B | 10 mg 100 mg 1 g | $112.00 $408.00 $3000.00 | 51 | |
Aprotinin is a protease inhibitor that can lead to the accumulation of proteins involved in the regulation of FBL20, potentially inhibiting its activity by disrupting its normal protein degradation pathway. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Omeprazole, while known as a proton pump inhibitor, can alter the cellular environment, potentially leading to the stabilization of proteins that regulate FBL20 and indirectly inhibit its function through effects on cellular signaling and protein turnover. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $130.00 $583.00 $4172.00 $20506.00 | 20 | |
Withaferin A can interfere with the proteasomal pathway, leading to the accumulation of proteins that regulate FBL20, which can inhibit the functional activity of FBL20 by altering its normal degradation and regulatory processes. | ||||||